{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T20:15:37Z","timestamp":1772309737346,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Latvian State Research Program","award":["2010.10-4\/VPP-4"],"award-info":[{"award-number":["2010.10-4\/VPP-4"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.bbr.2011.03.027","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T22:38:37Z","timestamp":1301351917000},"page":"26-32","source":"Crossref","is-referenced-by-count":27,"title":["Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats"],"prefix":"10.1016","volume":"222","author":[{"given":"Baiba","family":"Svalbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liga","family":"Zvejniece","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edijs","family":"Vavers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvalds","family":"Pugovics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Muceniece","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgars","family":"Liepinsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maija","family":"Dambrova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2011.03.027_bib0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1479-5876-7-97","article-title":"Inflammatory mechanisms in ischemic stroke: therapeutic approaches","volume":"7","author":"Lakhan","year":"2009","journal-title":"J Transl Med"},{"key":"10.1016\/j.bbr.2011.03.027_bib0010","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1523\/JNEUROSCI.23-34-10913.2003","article-title":"Long-lasting functional disabilities in middle-aged rats with small cerebral infarcts","volume":"23","author":"Lindner","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2011.03.027_bib0015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrn2735","article-title":"Plasticity during stroke recovery: from synapse to behaviour","volume":"10","author":"Murphy","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bbr.2011.03.027_bib0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1050-1738(02)00175-5","article-title":"Mildronate: cardioprotective action through carnitine-lowering effect","volume":"12","author":"Dambrova","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.bbr.2011.03.027_bib0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1527-3458.2005.tb00267.x","article-title":"Mildronate: an antiischemic drug for neurological indications","volume":"11","author":"Sjakste","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.bbr.2011.03.027_bib0030","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.fjc.0000250077.07702.23","article-title":"Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction","volume":"48","author":"Liepinsh","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.bbr.2011.03.027_bib0035","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1046\/j.1432-1327.2001.02065.x","article-title":"Development and characterization of an animal model of carnitine deficiency","volume":"268","author":"Spaniol","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bbr.2011.03.027_bib0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-2952(88)90717-4","article-title":"3-(2,2,2-Trimethylhydrazinium)propionate (THP) \u2013 a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties","volume":"37","author":"Simkhovich","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbr.2011.03.027_bib0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-3565(24)38111-X","article-title":"Pharmacokinetic analysis of the cardioprotective effect of 3-(2,2,2-trimethylhydrazinium) propionate in mice: inhibition of carnitine transport in kidney","volume":"289","author":"Kuwajima","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.03.027_bib0050","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.lfs.2008.08.008","article-title":"Mildronate decreases carnitine availability and up-regulates glucose uptake and related gene expression in the mouse heart","volume":"83","author":"Liepinsh","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2011.03.027_bib0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.fjc.0000211732.76668.d2","article-title":"Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics","volume":"47","author":"Sesti","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.bbr.2011.03.027_bib0060","first-page":"25","article-title":"Definition of therapeutic effect of mildronate in patients with chronic heart failure","author":"Chumburidze","year":"2005","journal-title":"Georgian Med News"},{"key":"10.1016\/j.bbr.2011.03.027_bib0065","first-page":"69","article-title":"Clinical efficacy and safety of mildronate in patients with ischemic heart disease and chronic heart failure","volume":"6","author":"Karpov","year":"2000","journal-title":"Kardiologija"},{"key":"10.1016\/j.bbr.2011.03.027_bib0070","first-page":"27","article-title":"Mildronate effects on oxidant stress in type 2 diabetic patients with diabetic peripheral (sensomotor) neuropathy","volume":"80","author":"Statsenko","year":"2008","journal-title":"Ter Arkh"},{"key":"10.1016\/j.bbr.2011.03.027_bib0075","first-page":"77","article-title":"The efficacy of the mildronate treatment of patients with ischemic stroke","author":"Vinichuk","year":"1991","journal-title":"Vrach Delo"},{"key":"10.1016\/j.bbr.2011.03.027_bib0080","first-page":"32","article-title":"Antioxidant activity of mildronate and l-carnitine in the treatment of patients with cerebrovascular diseases","volume":"66","author":"Suslina","year":"2003","journal-title":"Eksp Klin Farmakol"},{"key":"10.1016\/j.bbr.2011.03.027_bib0085","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/FBP.0b013e32833d5a59","article-title":"Mildronate exerts acute anticonvulsant and antihypnotic effects","volume":"21","author":"Zvejniece","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2011.03.027_bib0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-2999(00)00409-X","article-title":"Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats","volume":"400","author":"Jolkkonen","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2011.03.027_bib0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2011.03.027_bib0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbr.2007.10.030","article-title":"Social instability blocks functional restitution following motor cortex stroke in rats","volume":"188","author":"Silasi","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2011.03.027_bib0105","series-title":"The behaviour of the laboratory rat: a handbook with tests","first-page":"129","article-title":"Motor systems: orienting and placing","author":"Schallert","year":"2005"},{"key":"10.1016\/j.bbr.2011.03.027_bib0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.brainresbull.2005.08.018","article-title":"Talampanel improves the functional deficit after transient focal cerebral ischemia in rats. A 30-day follow up study","volume":"68","author":"Erdo","year":"2006","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bbr.2011.03.027_bib0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0166-4328(02)00241-3","article-title":"Behavioral deficits and recovery following transient focal cerebral ischemia in rats: glutamatergic and GABAergic receptor densities","volume":"138","author":"Jolkkonen","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2011.03.027_bib0120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.bbr.2011.03.027_bib0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jneumeth.2006.01.020","article-title":"Modification of the method of thread manufacture improves stroke induction rate and reduces mortality after thread-occlusion of the middle cerebral artery in young or aged rats","volume":"155","author":"Spratt","year":"2006","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.bbr.2011.03.027_bib0130","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0028-3908(00)00182-9","article-title":"An alpha(2)-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats","volume":"40","author":"Puurunen","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2011.03.027_bib0135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.expneurol.2008.02.024","article-title":"Enhanced function in the good forelimb of hemi-parkinson rats: compensatory adaptation for contralateral postural instability?","volume":"211","author":"Woodlee","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2011.03.027_bib0140","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.STR.0000169933.88903.cf","article-title":"Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats","volume":"36","author":"van","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.bbr.2011.03.027_bib0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.brainres.2006.09.056","article-title":"Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats","volume":"1123","author":"Makinen","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2011.03.027_bib0150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.physbeh.2008.06.012","article-title":"Effect of inhibiting carnitine biosynthesis on male rat sexual performance","volume":"95","author":"Dambrova","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2011.03.027_bib0155","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/089771503322385755","article-title":"Traumatic cerebral vascular injury: the effects of concussive brain injury on the cerebral vasculature","volume":"20","author":"DeWitt","year":"2003","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.bbr.2011.03.027_bib0160","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.bbr.2011.03.027_bib0165","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1067\/mhj.2000.103919","article-title":"Regulation of carbohydrate metabolism in ischemia and reperfusion","volume":"139","author":"Lopaschuk","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.bbr.2011.03.027_bib0170","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1440-1681.2008.04845.x","article-title":"Anti-oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemia-reperfusion injury in rats","volume":"35","author":"Dhote","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.bbr.2011.03.027_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(01)03095-5","article-title":"Trimetazidine as a potential neuroprotectant in transient global ischemia in gerbils: a behavioral and histological study","volume":"928","author":"Iqbal","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2011.03.027_bib0180","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1742-7843.2009.00461.x","article-title":"Effects of long-term mildronate treatment on cardiac and liver functions in rats","volume":"105","author":"Liepinsh","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.bbr.2011.03.027_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1320.001","article-title":"The role of the carnitine system in human metabolism","volume":"1033","author":"Foster","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bbr.2011.03.027_bib0190","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1471-4159.2004.02752.x","article-title":"Involvement of OCTN2 and B0, + in the transport of carnitine through an in vitro model of the blood\u2013brain barrier","volume":"91","author":"Berezowski","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2011.03.027_bib0195","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.mam.2004.06.001","article-title":"Carnitine: transport and physiological functions in the brain","volume":"25","author":"Na\u0142ecz","year":"2004","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.bbr.2011.03.027_bib0200","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/01.STR.0000198892.15269.f7","article-title":"Carnitine treatment inhibits increases in cerebral carnitine esters and glutamate detected by mass spectrometry after hypoxia\u2013ischemia in newborn rats","volume":"37","author":"Wainwright","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.bbr.2011.03.027_bib0205","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0006-8993(92)91117-W","article-title":"Preservation of energy metabolites by carnitine in the mouse brain under ischemia","volume":"590","author":"Matsuoka","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2011.03.027_bib0210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1196\/annals.1344.015","article-title":"l-Carnitine and neuroprotection in the animal model of mitochondrial dysfunction","volume":"1053","author":"Binienda","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bbr.2011.03.027_bib0215","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/01.STR.21.5.808","article-title":"Carnitine treatment for stroke in rats","volume":"21","author":"Slivka","year":"1990","journal-title":"Stroke"},{"key":"10.1016\/j.bbr.2011.03.027_bib0220","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10545-006-0355-3","article-title":"Prolonged moderate-intensity exercise without and with l-carnitine supplementation in patients with MCAD deficiency","volume":"29","author":"Huidekoper","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbr.2011.03.027_bib0225","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/j.1476-5381.2009.00319.x","article-title":"Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats","volume":"157","author":"Liepinsh","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2011.03.027_bib0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/dmrr.987","article-title":"Carnitine and type 2 diabetes","volume":"25","author":"Mynatt","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.bbr.2011.03.027_bib0235","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/10604450213832","article-title":"Involvement of nitric oxide production in the mildronate mechanism of action","volume":"12","author":"Dzintare","year":"2002","journal-title":"Pharmacol Rev Commun"},{"key":"10.1016\/j.bbr.2011.03.027_bib0240","first-page":"856","article-title":"The role of endogenous modulators of chemoreactivity in the regulation of coronary blood flow","volume":"88","author":"Sizova","year":"2002","journal-title":"Ross Fiziol Zh Im I M Sechenova"},{"key":"10.1016\/j.bbr.2011.03.027_bib0245","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ana.1249","article-title":"A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats","volume":"50","author":"Zhang","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2011.03.027_bib0250","first-page":"754","article-title":"The role of sildenafil in the treatment of stroke","volume":"9","author":"Bednar","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.bbr.2011.03.027_bib0255","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00000542-199108000-00022","article-title":"Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole","volume":"75","author":"Hoffman","year":"1991","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbr.2011.03.027_bib0260","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s007020170071","article-title":"Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat","volume":"108","author":"Kuhmonen","year":"2001","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2011.03.027_bib0265","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00540-009-0777-9","article-title":"Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats","volume":"23","author":"Nakano","year":"2009","journal-title":"J Anesth"},{"key":"10.1016\/j.bbr.2011.03.027_bib0270","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.neuroscience.2004.02.011","article-title":"Clonidine preconditioning decreases infarct size and improves neurological outcome from transient forebrain ischemia in the rat","volume":"125","author":"Zhang","year":"2004","journal-title":"Neuroscience"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432811002166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432811002166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:39:46Z","timestamp":1741113586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432811002166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0166432811002166"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2011.03.027","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}